Sequencing Considerations in mCRPC

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Sequencing Considerations in mCRPC

Sequencing Considerations in mCRPC

Playback speed

10 seconds

CARD Trial: Safety and Efficacy of Cabazitaxel in mCRPC & Age Subgroup Analysis

By Dana-Farber Cancer Institute FEATURING Atish Choudhury

157 views

July 28, 2022

0 Comments

Sequencing Considerations in mCRPC

Dana-Farber Cancer Institute

Lecture Summary - CARD Trial: Safety and Efficacy of Cabazitaxel in …

Feat. A. Choudhury

09:06

Dana-Farber Cancer Institute

CARD Trial: Safety and Efficacy of Cabazitaxel in mCRPC & Age Su…

Feat. A. Choudhury

08:33

Penn Medicine Abramson Cancer Center

Challenging Genitourinary Tumors: What’s New in Prostate Cancer

Feat. V. Narayan

22:50

Stanford Medicine

Genetics/Genomics in Prostate Cancer

Feat. M. Cooperberg

23:27

Stanford Medicine

Stanford Medicine Historical Landscape of Testing: Blood-Based Diagn…

Feat. J. Leppert

38:10

Nebraska Oncology Society

ASCO 2022 Updates on Molecular Based Imaging for Prostate Cancer: Re…

Feat. T. Hope

21:43

ecancer

ASCO 2022 on the Latest Developments in mHSPC and mCRPC

Feat. H. Payne, K. Chi, K. Miller, L. Krabbe

44:50

Masonic Cancer Center, University of Minnesota

New Therapeutic Discoveries and Mechanisms for CRPC

Feat. K. Kelly

14:33

Martin Allen-Auerbach

Prostate Cancer Imaging Updates: What, Why, and When

06:00

Elena Castro

Cabazitaxel Activity in Men With mCRPC With & Without DNA Damage…

10:02

Eleni Efstathiou

The Role of Biomarkers in mCRPC

13:49

Benjamin L. Maughan

Finding the Optimal Sequence for mCRPC

07:31

Karam Al-Issa

Second Line Therapy Options in mCRPC

06:12

Giulia Baciarello